The Wall Street Transcript
The interview was published October 21st.
The Wall Street Transcript The Wall Street Transcript - In-Depth Interviews for Investors
HOME
EXPERTS
REPORTS
PRODUCTS
NEWS
ABOUT US
CONTACT US
SEARCH
LOGIN
Series: Technology Healthcare Natural Resources Industry & Services Consumer Financial Services General Investing
Medical Research, Diagnostic Substances & Life Science Tools
October 21, 2016
Companies covered: BioTime, Inc. (AMEX:BTX), PhaseRx, Inc. (NASDAQ:PZRX), Dynatronics Corporation (NASDAQ:DYNT), Anavex Life Sciences Corp. (NASDAQ:AVXL), Cellectis S.A. (NASDAQ:CLLS), Digipath, Inc. (OTCMKTS:DIGP), EDAP TMS S.A. (NASDAQ:EDAP), BioSig Technologies Inc (OTCMKTS:BSGM), DelMar Pharmaceuticals Inc (NASDAQ:DMPI), Pressure BioSciences Inc. (OTCMKTS:PBIO), Clearside Biomedical Inc (NASDAQ:CLSD), Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Aimmune Therapeutics Inc (NASDAQ:AIMT), DBV Technologies S.A. (NASDAQ:DBVT), Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), Tobira Therapeutics Inc. (NASDAQ:TBRA), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), United Therapeutics Corporation (NASDAQ:UTHR), Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), Allergan, Inc. (NYSE:AGN), Edwards Lifesciences Corporation (NYSE:EW), Medtronic, Inc. (NYSE:MDT), ABIOMED, Inc. (NASDAQ:ABMD), Wright Medical Group, Inc. (NASDAQ:WMGI), DexCom, Inc. (NASDAQ:DXCM), Insulet Corporation (NASDAQ:PODD), ResMed Inc. (NYSE:RMD)
Buy ($175)
Interview with the President and CEO: PhaseRx, Inc. (NASDAQ:PZRX)
Robert W. Overell
Interview with the Founder, Chairman and CEO: Cellectis S.A. (NASDAQ:CLLS)
Andre Choulika
Interview with the Co-CEO: BioTime, Inc. (NYSEMKT:BTX)
Adi Mohanty
Interview with the Founder, COO and President and the Chief Science Officer: Digipath, Inc. (OTCMKTS:DIGP)
Todd Denkin; Cindy Orser
Continued Innovation and Stability in the Medical Device Space
Raj Denhoy
Interview with the CEO: EDAP TMS S.A. (NASDAQ:EDAP)
Marc Oczachowski
Interview with the President and CEO: Anavex Life Sciences Corp. (NASDAQ:AVXL)
Christopher U. Missling
Interview with the Chairman, President and CEO: Dynatronics Corporation (NASDAQ:DYNT)
Kelvyn H. Cullimore
High Risk and High Growth Potential in Small-Cap Life Sciences Space
Jay Albany
Investing in Best-in-Class Emerging Pharmaceuticals
Liana Moussatos
